Correction to: Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease

Affiliations

• ¹ Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland.
• ² Winterthur Institute of Health Economics, Zurich University of Applied Sciences, Winterthur, Switzerland.
• ³ Institute of Primary Care, University of Zurich, Zurich, Switzerland.
• ⁴ University Hospital Zurich, Zurich, Switzerland.
• ⁵ Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland. [email protected].